Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02968680 · ClinicalTrials.gov registry record · Phase 1
Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma
A Phase 1 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT02968680: Clinical Trial Phase 1 study, sponsored by University of Southern California.
NCT02968680 is a Phase 1 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02968680, a Phase 1 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This pilot phase I trial studies how well sonazoid-enhanced ultrasound works in detecting sentinel lymph node in patients with cutaneous melanoma. Sonazoid is a contrast agent that may make it easier to see if the tumor cells have spread to the sentinel lymph node using an ultrasound.
Primary Outcome
Analyzed using descriptive comparison.
Interventions
- PROCEDURE Sentinel Lymph Node Biopsy
- DRUG Sonazoid
- DEVICE Ultrasonography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-04-26 |
| Est. Completion | 2020-01-09 |
| Phase | Phase 1 |
Why NCT02968680 stopped before completion
NCT02968680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 3 interventions - of which Sentinel Lymph Node Biopsy is the first listed.
NCT02968680 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02968680 about?
NCT02968680 is a clinical study titled "Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma". This pilot phase I trial studies how well sonazoid-enhanced ultrasound works in detecting sentinel lymph node in patients with cutaneous melanoma. Sonazoid is a contrast agent that may make it easier to see if the tumor cells have spread to the sentinel lymph node using an ultrasound.
What is the current status of trial NCT02968680?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2017-04-26. Estimated completion is 2020-01-09.
What interventions are being tested in trial NCT02968680?
The interventions under investigation include: Sentinel Lymph Node Biopsy (PROCEDURE), Sonazoid (DRUG), Ultrasonography (DEVICE).
Who is sponsoring clinical trial NCT02968680?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02968680's enrollment target sits among peer trials
5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI